[1]
Li K, Du Y, Li L, Wei DQ. Bioinformatics approaches for anti-cancer drug discovery. Curr Drug Targets 2019; XX: xx.
[2]
Loganathan L, Gopinath K, Sankaranarayanan VM, et al. Computational and pharmacogenomics insights on hypertension treatment: rational drug design and optimization strategies. Curr Drug Targets 2019; XX: xx.
[3]
Fu J, Luo Y, Mou M, et al. Advances in current diabetes proteomics: from the perspectives of label-free quantification and biomarker selection. Curr Drug Targets 2019; XX: xx.
Article Metrics
29
5
1
3